Trenzyme receives approval for biosafety level 2 (BSL-2)

21-Oct-2010 - Germany
The Konstanz (Germany)-based Trenzyme GmbH just received approval for their biosafety level 2 (BSL-2) facility. Trenzyme is a biotech company offering a wide range of services in research and development for their customers. The company's core strengths are their cell line development as well as protein expression and purification businesses. Trenzyme offers exceptionally fast cell line development and employs expression systems from bacteria and yeast to insect and mammalian cells. Equally, the full range of molecular biology services is also available to their customers. By expanding their facility to accomodate BSL-2-classified projects Trenzyme once more guarantees their partners to stay ahead of the class.

Other news from the department politics & laws

Most read news

More news from our other portals

Fighting cancer: latest developments and advances